- Why It Matters: CHO’s collaboration with SIAM MEDICAN marks a significant milestone in Thailand’s medical cannabis industry, promising new treatments for patients and economic growth.
- The Big Picture: This venture reflects Thailand’s progressive shift towards embracing the medicinal benefits of cannabis, challenging outdated perceptions and legal constraints.
- What To Watch: The success of CHO and SIAM MEDICAN’s project could pave the way for further legalization and innovation within Thailand’s cannabis sector.
BANGKOK, THAILAND – In a landmark move for Thailand’s burgeoning medical cannabis industry, CHO Corporation has announced its full-scale venture into the production of medical-grade cannabis, in partnership with SIAM MEDICAN. This collaboration is set to revolutionize the availability of cannabis-based treatments in Thailand, with operations commencing in the second quarter of 2023.
SURADEJ THAVEESANGSUKTHAI, the CEO and Chairman of CHO, revealed that the latest progress includes obtaining the necessary licenses from the Food and Drug Administration under the Ministry of Public Health. This permit allows the cultivation of cannabis solely for medical purposes, marking a pivotal step towards the production of pharmaceutical-grade cannabis extracts, including CBD (Cannabidiol) and THC (Tetrahydrocannabinol).
The facility is gearing up to initiate the cultivation process within the first quarter of 2023, with an estimated annual yield of high-quality medical cannabis flowers ranging between 1,500 to 2,000 kilograms in its initial phase, eventually ramping up to 3,000 to 4,000 kilograms.
Targeting hospitals, medical establishments, clinics, and both domestic and international pharmaceutical companies, CHO aims to meet the growing demand for medical-grade cannabis and its derivatives. This venture not only signifies a major investment in creating new revenue streams for CHO but also supports Thailand’s ambition to become a global hub for herbal medicine, offering alternative treatments to patients worldwide.
As Thailand navigates the complexities of integrating cannabis into its healthcare and economic frameworks, CHO and SIAM MEDICAN’s pioneering project stands as a testament to the country’s forward-thinking approach to cannabis and its potential to enhance patient care and stimulate economic growth.
